NovoCure Ltd — Director's Dealing 2018

Mar 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-03-19

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-19	Ordinary Shares	M	49728	$0.23	Acquired	146558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-19	Options to Buy Ordinary Shares	$0.23	M	49728	Acquired	2019-01-10	Ordinary Shares (49728)	Direct

Footnotes

F1: Fully vested and currently exercisable as of the date hereof.